Tags: Drug.

SRT1720 is an experimental drug that was studied by Sirtris Pharmaceuticals intended as a small-molecule activator of the sirtuin subtype SIRT1. The compound has been studied in animals but safety and efficacy in humans have not been established.

SRT1720.svg
IUPAC name
N-[2-[3-(piperazin-1-ylmethyl)imidazo[21-b][13]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide
PubChem
24180125

Loading...

This page contains content from the copyrighted Wikipedia article "SRT1720"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.